The important role of serology for COVID-19 control

[1]  Chuan Qin,et al.  Reinfection could not occur in SARS-CoV-2 infected rhesus macaques , 2020 .

[2]  D. Jernigan,et al.  Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States, February 24, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[3]  Calvin J Chiew,et al.  Interrupting transmission of COVID-19: lessons from containment efforts in Singapore , 2020, Journal of travel medicine.

[4]  Jon Cohen,et al.  Wuhan seafood market may not be source of novel virus spreading globally , 2020 .

[5]  Sha Lin,et al.  Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset , 2020, medRxiv.

[6]  T. Matsuda,et al.  Phylogenetic analyses of the severe acute respiratory syndrome coronavirus 2 reflected the several routes of introduction to Taiwan, the United States, and Japan , 2020, 2002.08802.

[7]  S. Blomqvist,et al.  Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  M. Battegay,et al.  2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. , 2020, Swiss medical weekly.

[9]  Zheng Zhao,et al.  Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures , 2020, The Lancet.

[10]  Philip L. Felgner,et al.  A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, medRxiv.

[11]  R. Brook,et al.  Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. , 2020, JAMA.

[12]  Po Ying Chia,et al.  Connecting clusters of COVID-19: an epidemiological and serological investigation , 2020, The Lancet Infectious Diseases.

[13]  M. Day.  Covid-19: surge in cases in Italy and South Korea makes pandemic look more likely , 2020, BMJ.

[14]  M. Lipsitch,et al.  Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China , 2020, The Lancet Infectious Diseases.

[15]  Xiang Li,et al.  On the origin and continuing evolution of SARS-CoV-2 , 2020, National science review.

[16]  R. Trimble.  COVID-19 Dashboard , 2020 .

[17]  Yuan Shi,et al.  Convalescent plasma as a potential therapy for COVID-19 , 2020, The Lancet Infectious Diseases.